Kawasaki, Japan

Wataru Miyanaga


Average Co-Inventor Count = 9.3

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Kanagawa, JP (2013)
  • Kawasaki, JP (2011 - 2016)
  • Chuo-ku, JP (2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Wataru Miyanaga: Innovator in Pharmaceutical Chemistry

Introduction

Wataru Miyanaga is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of seven patents. His work primarily focuses on developing innovative compounds with therapeutic applications.

Latest Patents

Among his latest patents is a compound titled "Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity." This invention provides a sulfonamide derivative that exhibits inhibitory action on the α4 integrin. Another notable patent is for a "Remedy for diabetes," which outlines a method for screening compounds with hypoglycemic effects. This method identifies compounds capable of binding to the β subunit of a trimeric GTP-binding protein, offering a novel approach to diabetes treatment.

Career Highlights

Wataru Miyanaga has worked with reputable companies such as Ajinomoto Co., Ltd. and Ea Pharma Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Throughout his career, Miyanaga has collaborated with notable colleagues, including Masaru Takayanagi and Takao Ikenoue. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Wataru Miyanaga is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in diabetes treatment and integrin inhibition. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…